United Laboratories International 

€1.14
3
+€0.01+0.88% Thursday 09:55

Statistics

Day High
1.1
Day Low
1.1
52W High
1.87
52W Low
1.03
Volume
-
Avg. Volume
-
Mkt Cap
2.07B
P/E Ratio
6.13
Dividend Yield
4.61%
Dividend
0.05

Upcoming

Dividends

4.61%Dividend Yield
Oct 25
€0.02
Jul 25
€0.03
Jul 25
€0.01
Oct 24
€0.02
Jul 24
€0.02
10Y Growth
N/A
5Y Growth
27.2%
3Y Growth
16.03%
1Y Growth
N/A

Earnings

24MarExpected
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
0.01
0.06
0.11
0.16
Expected EPS
0.00738359808
Actual EPS
0.00738359808

Financials

19.32%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
3.61BRevenue
698.39MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow UNJ.F. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. is a major global pharmaceutical company that competes in various therapeutic areas similar to United Laboratories.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. offers a broad range of pharmaceutical products that directly compete with United Laboratories in multiple markets.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the pharmaceuticals sector, providing similar products and competing in similar markets as United Laboratories.
GSK
GSK
Mkt Cap94.51B
GlaxoSmithKline plc is a competitor due to its extensive range of pharmaceutical products that overlap with United Laboratories' product line.
Novartis
NVS
Mkt Cap237.61B
Novartis AG competes with United Laboratories in the development and marketing of drugs in various therapeutic areas.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie Inc. competes in the pharmaceutical industry, offering products in areas like immunology and oncology, similar to United Laboratories.
Sanofi
SNY
Mkt Cap124.45B
Sanofi operates globally in the pharmaceutical sector, competing directly with United Laboratories in several therapeutic categories.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb Company offers a wide range of pharmaceutical products that compete with United Laboratories' offerings.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca PLC has a significant presence in the pharmaceutical industry, competing in similar therapeutic areas as United Laboratories.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG competes with United Laboratories through its comprehensive drug portfolio and global market presence.

About

The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, nervous system drugs, vitamins, and vacant gelatin capsules, as well as API and intermediate products. It also manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, other Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.
Show more...
CEO
Mr. Hoi Shan Tsoi
Employees
14000
Country
KY
ISIN
KYG8813K1085
WKN
000A0MUFS

Listings

0 Comments

Share your thoughts

FAQ

What is United Laboratories International stock price today?
The current price of UNJ.F is €1.14 EUR — it has increased by +0.88% in the past 24 hours. Watch United Laboratories International stock price performance more closely on the chart.
What is United Laboratories International stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange United Laboratories International stocks are traded under the ticker UNJ.F.
Is United Laboratories International stock price growing?
UNJ.F stock has risen by +3.64% compared to the previous week, the month change is a -16.79% fall, over the last year United Laboratories International has showed a -28.75% decrease.
What is United Laboratories International market cap?
Today United Laboratories International has the market capitalization of 2.07B
When is the next United Laboratories International earnings date?
United Laboratories International is going to release the next earnings report on August 27, 2026.
What were United Laboratories International earnings last quarter?
UNJ.F earnings for the last quarter are 0.01 EUR per share, whereas the estimation was 0.01 EUR resulting in a +0% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is United Laboratories International revenue for the last year?
United Laboratories International revenue for the last year amounts to 3.61B EUR.
What is United Laboratories International net income for the last year?
UNJ.F net income for the last year is 698.39M EUR.
Does United Laboratories International pay dividends?
Yes, UNJ.F dividends are paid semi-annual. The last dividend per share was 0.02 EUR. As of today, Dividend Yield (FWD)% is 4.61%.
How many employees does United Laboratories International have?
As of April 05, 2026, the company has 14,000 employees.
In which sector is United Laboratories International located?
United Laboratories International operates in the Health Care sector.
When did United Laboratories International complete a stock split?
United Laboratories International has not had any recent stock splits.
Where is United Laboratories International headquartered?
United Laboratories International is headquartered in Yuen Long, KY.